Clinical Trials Browser

OTHER × Sarcoma × palbociclib × Clear all

NCT06113809 2026-05-22

Palbociclib and Pembrolizumab in Sarcoma

Phase 1 Recruiting

Sarcoma

NCT04129151 2024-08-01

Palbociclib + Ganitumab In Ewing Sarcoma

Phase 2 Terminated

10 enrolled 15 charts

Recurrence, Sarcoma, Sarcoma, Ewing

NCT03242382 2024-01-23

PalboSarc

Phase 2 Unknown

Chordoma, Sarcoma, Osteosarcoma

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT02897375 2023-10-10

Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors

Phase 1 Completed

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT01209598 2017-11-06

PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma

Phase 2 Completed

90 enrolled 7 charts

Liposarcoma, Sarcoma